Summary

Soft Mist Inhalers Market – Scope of Report
TMR’s report on the global soft mist inhalers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global soft mist inhalers market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global soft mist inhalers market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the soft mist inhalers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global soft mist inhalers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global soft mist inhalers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global soft mist inhalers market.

The report delves into the competitive landscape of the global soft mist inhalers market. Key players operating in the global soft mist inhalers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global soft mist inhalers market profiled in this report.

Key Questions Answered in Global soft mist inhalers Market Report
• What is the sales/revenue generated by soft mist inhalers across all regions during the forecast period?
• What are the opportunities in the global soft mist inhalers market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Soft Mist Inhalers Market – Research Objectives and Research Approach
The comprehensive report on the global soft mist inhalers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global soft mist inhalers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global soft mist inhalers market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Soft Mist Inhalers Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Soft Mist Inhalers Market Analysis and Forecasts, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Regulatory Scenario by Region/Globally
5.3. Disease Prevalence & Incidence Rate Globally with Key Countries
5.4. COVID-19 Impact Analysis
6. Global Soft Mist Inhalers Market Analysis and Forecasts, By Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Type, 2017-2031
6.3.1. Disposable
6.3.2. Reusable
6.4. Market Attractiveness By Type
7. Global Soft Mist Inhalers Market Analysis and Forecasts, By Age Group
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Age Group, 2017-2031
7.3.1. Adults
7.3.2. Pediatrics
7.4. Market Attractiveness By Age Group
8. Global Soft Mist Inhalers Market Analysis and Forecasts, By Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Application, 2017-2031
8.3.1. Asthma
8.3.2. COPD
8.3.3. Others (Cystic Fibrosis, etc.)
8.4. Market Attractiveness By Application
9. Global Soft Mist Inhalers Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Others (Home Care, etc.)
9.4. Market Attractiveness By End-user
10. Global Soft Mist Inhalers Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Soft Mist Inhalers Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Type, 2017-2031
11.2.1. Disposable
11.2.2. Reusable
11.3. Market Value Forecast By Age Group, 2017-2031
11.3.1. Adults
11.3.2. Pediatrics
11.4. Market Value Forecast By Application, 2017-2031
11.4.1. Asthma
11.4.2. COPD
11.4.3. Others (Cystic Fibrosis, etc.)
11.5. Market Value Forecast By End-user, 2017-2031
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Others (Home Care, etc.)
11.6. Market Value Forecast By Country, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Type
11.7.2. By Age Group
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Soft Mist Inhalers Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Type, 2017-2031
12.2.1. Disposable
12.2.2. Reusable
12.3. Market Value Forecast By Age Group, 2017-2031
12.3.1. Adults
12.3.2. Pediatrics
12.4. Market Value Forecast By Application, 2017-2031
12.4.1. Asthma
12.4.2. COPD
12.4.3. Others (Cystic Fibrosis, etc.)
12.5. Market Value Forecast By End-user, 2017-2031
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Others (Home Care, etc.)
12.6. Market Value Forecast By Country, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Type
12.7.2. By Age Group
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country
13. Asia Pacific Soft Mist Inhalers Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Type, 2017-2031
13.2.1. Disposable
13.2.2. Reusable
13.3. Market Value Forecast By Age Group, 2017-2031
13.3.1. Adults
13.3.2. Pediatrics
13.4. Market Value Forecast By Application, 2017-2031
13.4.1. Asthma
13.4.2. COPD
13.4.3. Others (Cystic Fibrosis, etc.)
13.5. Market Value Forecast By End-user, 2017-2031
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Others (Home Care, etc.)
13.6. Market Value Forecast By Country, 2017-2031
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Type
13.7.2. By Age Group
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country
14. Latin America Soft Mist Inhalers Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Type, 2017-2031
14.2.1. Disposable
14.2.2. Reusable
14.3. Market Value Forecast By Age Group, 2017-2031
14.3.1. Adults
14.3.2. Pediatrics
14.4. Market Value Forecast By Application, 2017-2031
14.4.1. Asthma
14.4.2. COPD
14.4.3. Others (Cystic Fibrosis, etc.)
14.5. Market Value Forecast By End-user, 2017-2031
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Others (Home Care, etc.)
14.6. Market Value Forecast By Country, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Type
14.7.2. By Age Group
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Soft Mist Inhalers Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Type, 2017-2031
15.2.1. Disposable
15.2.2. Reusable
15.3. Market Value Forecast By Age Group, 2017-2031
15.3.1. Adults
15.3.2. Pediatrics
15.4. Market Value Forecast By Application, 2017-2031
15.4.1. Asthma
15.4.2. COPD
15.4.3. Others (Cystic Fibrosis, etc.)
15.5. Market Value Forecast By End-user, 2017-2031
15.5.1. Hospitals
15.5.2. Clinics
15.5.3. Others (Home Care, etc.)
15.6. Market Value Forecast By Country, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Type
15.7.2. By Age Group
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles
16.2.1. Recipharm
16.2.2. Boehringer Ingelheim
16.2.3. Merxin Ltd
16.2.4. DSB Medical Co., Ltd.
16.2.5. Resyca BV
16.2.6. Aero Pump GmbH
16.2.7. Ursatec GmbH
17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of companies)
17.2. Market Share Analysis By Company (2022)
17.3. Company Profiles
17.3.1. Recipharm
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Material Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Boehringer Ingelheim
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Material Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Merxin Ltd.
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Material Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. DSB Medical Co., Ltd.
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Material Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Resyca BV
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Material Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. Aero Pump GmbH
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Material Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Ursatec GmbH
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Material Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview